AstraZeneca COVID-19 shots stopped by several European nations amid blood clot reports, but EU regulator says no evidence of link
4 years ago

AstraZeneca COVID-19 shots stopped by several European nations amid blood clot reports, but EU regulator says no evidence of link

ABC  

Several European nations have suspended use of AstraZeneca's COVID-19 vaccine following reports of blood clots, but the European medicine regulator says there is no evidence of a link. Key points: A 60-year-old woman formed a blood clot and died after being given an AstraZeneca shot There is no conclusive link between the vaccine and blood clots, and the suspensions are precautionary Other nations including Italy and Austria have stopped using some of their AstraZeneca supply until more testing is done Denmark suspended the shots for two weeks after a 60-year-old woman who was given an AstraZeneca shot from a batch used in Austria formed a blood clot and died, health authorities said. "There is nothing to indicate that the vaccine causes this type of blood clots," said Veronica Arthurson, head of drug safety at the Swedish Medical Products Agency. Spain said it had not registered any cases of blood clots related to AstraZeneca's vaccine so far, and would continue administering the shots.

France Evidence Blood Clots Blood Covid European Nations Continue Vaccine No Evidence Astrazeneca Ema Batch Blood Clotting  vaccinated  evidence  eu  astrazeneca  reports  european  batch  vaccine  continue  covid19  clots  link  blood  shots  regulator  stopped  nations  cases

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
10 months, 2 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
10 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca: What are the rare side effects of the Covid jab?
10 months, 2 weeks ago

AstraZeneca: What are the rare side effects of the Covid jab?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy AstraZeneca has announced it initiated a worldwide withdrawal of its Covid-19 …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
10 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

The truth about AstraZeneca’s Covid vaccine
10 months, 2 weeks ago

The truth about AstraZeneca’s Covid vaccine

The Independent  

Within 24 hours of my first Covid vaccine, I was in bed, feeling like I had just gone 10 rounds with Mike Tyson. Nonetheless, when it came to the second shot of the Oxford-AstraZeneca Covid vaccine, I was at the front of the queue in the full knowledge of what might happen. Airfinity, a disease forecasting tech company, used that …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
10 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
10 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
10 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca begins global withdrawal of Covid-19 vaccines: This is the reason
10 months, 2 weeks ago

AstraZeneca begins global withdrawal of Covid-19 vaccines: This is the reason

Op India  

On Tuesday, AstraZeneca announced that it has begun the global withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the epidemic. “As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” AstraZeneca said. AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorisations for Vaxzevria …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
10 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
10 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

Study vaccine, assure people on its safety
10 months, 3 weeks ago

Study vaccine, assure people on its safety

New Indian Express  

Concerns about the safety of Covid vaccines have returned with pharmaceutical giant AstraZeneca admitting that its vaccine, developed in collaboration with Oxford University, can have a rare but serious side effect. Experts say the admission by AstraZeneca, though serious, need not cause panic as it’s a rare side effect, rarer still among Asians and South Americans. A study found 8.1 …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
10 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots
10 months, 3 weeks ago

AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots

The Hindu  

Following pharmaceutical company AstraZeneca’s admission in U.K. court documents that its vaccine against COVID-19 has the potential to cause Thrombosis with Thrombocytopenia Syndrome, a rare side effect associated with blood clotting, doctors in India said this is not new information and that they are “well aware of the warning which has been available in India as an insert with the …

In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
10 months, 3 weeks ago

In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, …

AstraZeneca admits its Covishield vaccine may lead to rare side effect
10 months, 4 weeks ago

AstraZeneca admits its Covishield vaccine may lead to rare side effect

New Indian Express  

As reported by The Telegraph, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine "can, in very rare instances, lead to TTS." AstraZeneca, in a May 2023 response to Scott's lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a …

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?
10 months, 3 weeks ago

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

Hindustan Times  

Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. {{^usCountry}} {{/usCountry}} AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with the help of University of Oxford, has led to several deaths and serious injury. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Responding to Scott's …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
10 months, 3 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle
1 year, 2 months ago

AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle

Daily Mail  

AstraZeneca is is facing tens of millions of pounds in compensation claims from 35 alleged victims over complications they say were caused by the Covid-19 vaccine. The pharmaceutical giant, which developed its jab in partnership with the University of Oxford, is set to face a High Court battle over claims the vaccine is 'defective' MP Sir Jeremy Wright has been …

'Vaccine victims' left with life-changing injuries from the Oxford-AstraZeneca Covid jab say they've been censored online when speaking out
1 year, 2 months ago

'Vaccine victims' left with life-changing injuries from the Oxford-AstraZeneca Covid jab say they've been censored online when speaking out

Daily Mail  

People who were left with life-changing injuries after being given the Oxford-AstraZeneca Covid jab claim they have been censored while trying to speak out on social media about their symptoms. They believe they are vaccine victims who suffered a number of severe reactions, including a father-of-two who formed a blood clot after being given the vaccine in spring 2021 causing …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year, 3 months ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims
1 year, 3 months ago

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims

The Telegraph  

Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed. Two of the studies looked at rates of GBS in England and said there was an increase in cases “attributable to” the AstraZeneca vaccine, or that there was a probable “causal link”. ‘Side effects ignored’ Anthony …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 4 months ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect
1 year, 4 months ago

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect

Daily Mail  

AstraZeneca said jab has 'acceptable safety profile' and regulators state that the benefits outweigh the risks of 'extremely rare potential side-effects' The jabs were dished out 50million times in the UK during the Covid pandemic The AstraZeneca Covid vaccine has been labelled 'defective' in a multi-million-pound lawsuit by patients who suffered a rare side-effect. IT engineer Jamie Scott suffered a …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 4 months ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

The victims of AstraZeneca's vaccine
1 year, 10 months ago

The victims of AstraZeneca's vaccine

Daily Mail  

Jab complications were rare but the massive rollout saw dozens of Brits killed Covid vaccines are estimated to have saved millions of lives, by both protecting people from the virus and helping end the paralysing series of lockdowns. An inquest heard he was told there was no Pfizer jab in stock and was given out-of-date information in relation to blood …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 5 months ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 5 months ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 10 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

EU regulator advises AstraZeneca’s COVID drug be cleared
3 years ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'
3 years ago

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'

News 18  

The EU’s drug watchdog on Thursday recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. The European Medicines Agency’s human medicines committee “has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years …

AstraZeneca set to abandon push for US vaccine approval
3 years ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
3 years, 1 month ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

Covid-19 Australia: UK doctor slams scientists and politicians of damaging reputation of AstraZeneca
3 years, 1 month ago

Covid-19 Australia: UK doctor slams scientists and politicians of damaging reputation of AstraZeneca

Daily Mail  

An Oxford scientist who worked on the AstraZeneca vaccine believes scientists and politicians 'probably killed hundreds of thousands of people' by damaging the reputation of the jab. Professor Sir John Bell claims critical comments from leaders such as French President Emmanuel Macron had eroded public trust in the vaccine globally. An Oxford scientist who worked on the AstraZeneca vaccine claims …

Accepting Covid-19 virus: European countries to adopt new strategy
3 years, 2 months ago

Accepting Covid-19 virus: European countries to adopt new strategy

India Today  

When the coronavirus pandemic was first declared, Spaniards were ordered to stay home for more than three months. Sánchez said the changes should not happen before the omicron surge is over, but officials need to start shaping the post-pandemic world now: “We are doing our homework, anticipating scenarios.” READ | Cheap version of Merck Covid pill to be made for …

So when WILL Covid chaos end?
3 years, 3 months ago

So when WILL Covid chaos end?

Daily Mail  

Britain could face another year-and-a-half of Covid misery despite a hugely successful vaccination drive, scientists have warned on the back of data showing immunity from booster jabs starts to fade after just 10 weeks. Early real-world analysis of the UK's immunisation scheme shows the efficacy of Pfizer's top-up dose at preventing symptoms drops to as low as 35 per cent …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years, 3 months ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

Omicron brings COVID-19 vaccine inequity ‘home to roost’
3 years, 3 months ago

Omicron brings COVID-19 vaccine inequity ‘home to roost’

Associated Press  

LONDON — The emergence of the new omicron variant and the world’s desperate and likely futile attempts to keep it at bay are reminders of what scientists have warned for months: The coronavirus will thrive as long as vast parts of the world lack vaccines. “The COVAX team may be delivering as fast as they can, but they can’t deliver …

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm
3 years, 4 months ago

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm

The Telegraph  

It is the key question puzzling scientists and commentators – how is Britain managing to weather the latest deadly Covid storm while our European neighbours' defences are crumbling? He suggested that the durability of T-cells from the Oxford/AstraZeneca jab could be keeping older people safer than those on the continent, preventing hospitilisations and deaths even though virus cases are still …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 4 months ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 5 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment
3 years, 5 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 5 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorize COVID antibody treatment
3 years, 5 months ago

AstraZeneca asks FDA to authorize COVID antibody treatment

LA Times  

AstraZeneca has asked the Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The Anglo-Swedish company said Tuesday that the …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 5 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 6 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

AstraZeneca shot co-creator says recipients 'more likely to get blood clots from COVID than from the vaccine'
3 years, 6 months ago

AstraZeneca shot co-creator says recipients 'more likely to get blood clots from COVID than from the vaccine'

ABC  

Sarah Gilbert is the architect of Oxford University’s AstraZeneca COVID-19 vaccine. Key points: Professor Sarah Gilbert says regular booster shots of COVID-19 vaccines are unlikely to be necessary Professor Sarah Gilbert says regular booster shots of COVID-19 vaccines are unlikely to be necessary She says the AstraZeneca vaccine was created quickly because "we cut out as much of the waiting …

Worried about getting AstraZeneca? The experts answer your questions
3 years, 6 months ago

Worried about getting AstraZeneca? The experts answer your questions

ABC  

A lot of Australians are still worried about the AstraZeneca vaccine but experts say there is no reason for the vast majority not to get it. Dr Price says those conditions include: Central venous sinus thrombosis Heparin-induced thrombocytopenia with thrombosis, where heparin is the medication Capillary leak syndrome Antiphospholipid syndrome Idiopathic splanchnic vein thrombosis Polysorbate 80 anaphylaxis Previous thrombocytopenia syndrome …

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study
3 years, 6 months ago

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study

Firstpost  

The study estimated that for 10 million people who received the AstraZeneca jab, there were seven additional cases, compared to 20 in people with Covid infection. Fears over rare cases of clotting conditions have prompted some countries to rule out or limit rollout of the Oxford-developed AstraZeneca jab, with the UK recommending that healthy people under 40 get alternative vaccines. …

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows
3 years, 7 months ago

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows

LA Times  

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer plant in Portage, Mich. COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with the AstraZeneca or Pfizer shots, according to a large U.K. study. For every 10 million people who receive the first dose of AstraZeneca, about 66 more will …

Discover Related